← Leaderboards
David W. Carley
University Of Illinois At Chicago
$5,671,894
Attributed
$8,647,174
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2006–14$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$13,505,947 · 5
By mechanism
UM1$9,321,693 · 2
R01$4,076,134 · 1
R13$94,086 · 1
M01$14,034 · 1
Top collaborators
- Miodrag G Radulovacki6 shared
- Phyllis C Zee6 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Miodrag G Radulovacki$3,188,150
- Anne M Fink$1,049,465
- Thomas R Stratford$1,104,763
- Stephen Reilly$5,538,888
- David Wirtshafter$830,111
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingSleepAnimalsMotorSleep Apnea SyndromesApneaBreathingPatternReceptorBaseConsciousRespiratoryInsightPhysiologicalGenerationsBehavioralNeuronsRem SleepBrain StemAgonistPathway InteractionsClinical ResearchPathogenesisSynapses
Grant awards (22)
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial$1,881,836
UM1 · FY2014 · HL · contact PI
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial$1,749,525
UM1 · FY2014 · HL · contact PI
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial$1,981,987
UM1 · FY2013 · HL · contact PI
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial$1,853,456
UM1 · FY2013 · HL · contact PI
Neurobiology of Sleep Apnea in Aging$308,991
R01 · FY2013 · AG · contact PI
Cannabimimetic treatment of obstructive sleep apnea: A proof of concept trial$994,950
UM1 · FY2012 · HL · contact PI
Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial$859,939
UM1 · FY2012 · HL · contact PI
Neurobiology of Sleep Apnea in Aging$326,975
R01 · FY2012 · AG · contact PI
Sleep-Dependent Determinants of Biobehavioral Function$44,543
R13 · FY2012 · HL · contact PI
Neurobiology of Sleep Apnea in Aging$325,950
R01 · FY2011 · AG · contact PI
Sleep-Dependent Determinants of Biobehavioral Function$49,543
R13 · FY2011 · HL · contact PI
Neurobiology of sleep apnea in aging$454,157
R01 · FY2010 · AG · contact PI
Neurobiology of sleep apnea in aging$302,365
R01 · FY2009 · AG · contact PI
Neurobiology of sleep apnea in aging$156,380
R01 · FY2009 · AG · contact PI
Neurobiology of sleep apnea in aging$302,365
R01 · FY2008 · AG · contact PI
Neurobiology of sleep apnea in aging$308,535
R01 · FY2007 · AG · contact PI
Neurobiology of sleep apnea in aging$317,750
R01 · FY2006 · AG · contact PI
Neurobiology of Sleep Apnea in Aging$14,034
M01 · FY2004 · RR
NEUROBIOLOGY OF SLEEP APNEA IN AGING$330,778
R01 · FY2003 · AG
NEUROBIOLOGY OF SLEEP APNEA IN AGING$322,202
R01 · FY2002 · AG
NEUROBIOLOGY OF SLEEP APNEA IN AGING$313,883
R01 · FY2001 · AG
NEUROBIOLOGY OF SLEEP APNEA IN AGING$305,803
R01 · FY2000 · AG